Why did Canada rescind its digital services tax?
How will Senate GOP bill impact clean energy credits?
What caused Robinhood stock to hit record highs?
Why is Tesla’s robotaxi service facing skepticism?
How are AI hiring sprees boosting Meta’s stock?
What delays are affecting Joby Aviation’s flying taxis?
Why is Home Depot acquiring specialty building distributors?
Vor Biopharma's $4 Billion Investment Paves Way For Multi-Billion Dollar Autoimmune Market
benzinga.com/analyst-stock-ratings/upgrades/25/06/46178037/vor-biopharmas-125-million-investment-paves-way-for-multi-billion-dollar-autoimmun
H.C. Wainwright upgraded Vor Biopharma Inc. (NASDAQ:VOR), highlighting the company’s “rebirth” following the in-licensing of telitacicept.
On Thursday, the company announced a strategic licensing agreement and a major capital raise to support its push into autoimmune therapies.
Vor Bio…
This story appeared on benzinga.com, 2025-06-30 18:31:52.